{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T23:26:39Z","timestamp":1773012399490,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.josat.2024.209586","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T16:38:27Z","timestamp":1732898307000},"page":"209586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Redefining low-threshold buprenorphine access in an integrated mobile clinic program: Factors associated with treatment retention"],"prefix":"10.1016","volume":"169","author":[{"given":"Robert","family":"Harris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norberth","family":"Stracker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"St. Clair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Page","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Rosecrans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.josat.2024.209586_bb0005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12954-023-00888-6","article-title":"Examining buprenorphine diversion through a harm reduction lens: An agent-based modeling study","volume":"20","author":"Adams","year":"2023","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.josat.2024.209586_bb0010","author":"Ahmad"},{"key":"10.1016\/j.josat.2024.209586_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2023.209193","article-title":"Disparities in access to opioid treatment programs and buprenorphine providers by race and ethnicity in the contiguous U.S","volume":"156","author":"Amiri","year":"2024","journal-title":"Journal of Substance use and Addiction Treatment"},{"issue":"19","key":"10.1016\/j.josat.2024.209586_bb0020","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMsa2212412","article-title":"Racial inequality in receipt of medications for opioid use disorder","volume":"388","author":"Barnett","year":"2023","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.josat.2024.209586_bb0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13722-017-0072-2","article-title":"Public sector low threshold office-based buprenorphine treatment: Outcomes at year 7","volume":"12","author":"Bhatraju","year":"2017","journal-title":"Addiction Science & Clinical Practice"},{"issue":"1","key":"10.1016\/j.josat.2024.209586_bb1000","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12954-020-00381-4","article-title":"When is an abscess more than an abscess? Syringe services programs and the harm reduction safety-net: A case report","volume":"17","author":"Castillo","year":"2020","journal-title":"Harm Reduction Journal"},{"issue":"2","key":"10.1016\/j.josat.2024.209586_bb0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/HRP.0000000000000075","article-title":"Medication-assisted treatment of opioid use disorder: Review of the evidence and future directions","volume":"23","author":"Connery","year":"2015","journal-title":"Harvard Review of Psychiatry"},{"issue":"1","key":"10.1016\/j.josat.2024.209586_bb0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/08897077231165619","article-title":"Buprenorphine prescribing and dosing limits: Evidence and policy goals","volume":"44","author":"Coyle","year":"2023","journal-title":"Substance Abuse"},{"issue":"2","key":"10.1016\/j.josat.2024.209586_bb0040","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1353\/hpu.2017.0065","article-title":"Innovative program delivery and determinants of frequent visitation to a mobile medical clinic in an urban setting","volume":"28","author":"Gibson","year":"2017","journal-title":"Journal of Health Care for the Poor and Underserved"},{"key":"10.1016\/j.josat.2024.209586_bb0045","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000001189","article-title":"Evidence on buprenorphine dose limits: A review","author":"Grande","year":"2023","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.josat.2024.209586_bb0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12954-023-00906-7","article-title":"Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder","volume":"20","author":"Greenwald","year":"2023","journal-title":"Harm Reduction Journal"},{"issue":"1","key":"10.1016\/j.josat.2024.209586_bb0055","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/07853890.2021.2022188","article-title":"Awareness, perception and utilization of a mobile health clinic by people who use drugs","volume":"54","author":"Grieb","year":"2022","journal-title":"Annals of Medicine"},{"issue":"2","key":"10.1016\/j.josat.2024.209586_bb0060","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"Journal of Biomedical Informatics"},{"key":"10.1016\/j.josat.2024.209586_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109187","article-title":"Utilizing telemedicine during COVID-19 pandemic for a low-threshold, street-based buprenorphine program","volume":"230","author":"Harris","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2024.209586_bb0070","article-title":"Access challenges to opioid use disorder treatment among individuals experiencing homelessness: Voices from the streets","volume":"157","author":"Hsu","year":"2023","journal-title":"Journal of Substance use and Addiction Treatment"},{"issue":"8","key":"10.1016\/j.josat.2024.209586_bb2000","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2105\/AJPH.2020.305681","article-title":"Community wound care program within a syringe exchange program: Chicago, 2018-2019","volume":"110","author":"Huyck","year":"2020","journal-title":"American Journal of Public Health"},{"issue":"1","key":"10.1016\/j.josat.2024.209586_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-022-00654-0","article-title":"Implementation of buprenorphine services in NYC syringe services programs: A qualitative process evaluation","volume":"19","author":"Jakubowski","year":"2022","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.josat.2024.209586_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.12.021","article-title":"Opioid substitution therapy: Lowering the treatment thresholds","volume":"161","author":"Kourounis","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2024.209586_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2019.05.002","article-title":"Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap","volume":"103","author":"Krawczyk","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2024.209586_bb0090","series-title":"Addiction (Abingdon, England)","article-title":"Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services","author":"Krawczyk","year":"2020"},{"issue":"3","key":"10.1016\/j.josat.2024.209586_bb0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: A cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.josat.2024.209586_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.109915","article-title":"\u201cCome try it out. Get your foot in the door:\u201d exploring patient perspectives on low-barrier treatment for opioid use disorder","volume":"248","author":"Lowenstein","year":"2023","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2024.209586_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108717","article-title":"Opioid use disorder treatment for people experiencing homelessness: A scoping review","volume":"224","author":"McLaughlin","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2024.209586_bb0110","article-title":"Outcomes of a mobile medical unit for low-threshold buprenorphine access targeting opioid overdose hot spots in Chicago","volume":"209054","author":"Messmer","year":"2023","journal-title":"Journal of Substance use and Addiction Treatment"},{"key":"10.1016\/j.josat.2024.209586_bb0115","article-title":"Is there a disparity in medications for opioid use disorder based on race\/ethnicity and gender? A systematic review and meta-analysis","author":"Nedjat","year":"2023","journal-title":"Research in Social & Administrative Pharmacy: RSAP"},{"key":"10.1016\/j.josat.2024.209586_bb0120","article-title":"Adapting a low-threshold buprenorphine program for vulnerable populations during the COVID-19 pandemic","author":"Nordeck","year":"2020","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2024.209586_bb0125","article-title":"Expanding buprenorphine treatment to people experiencing homelessness through a mobile, multidisciplinary program in an urban, underserved setting","volume":"127","author":"O\u2019Gurek","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2024.209586_bb0130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.drugalcdep.2019.03.009","article-title":"Effect of lowering initiation thresholds in a primary care-based buprenorphine treatment program","volume":"200","author":"Payne","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2024.209586_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1154813","article-title":"A mobile addiction service for community-based overdose prevention","volume":"11","author":"Pepin","year":"2023","journal-title":"Frontiers in Public Health"},{"key":"10.1016\/j.josat.2024.209586_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108155","article-title":"Down the drain: Reconsidering routine urine drug testing during the COVID19 pandemic","volume":"120","author":"Pytell","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"11","key":"10.1016\/j.josat.2024.209586_bb3000","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.2105\/AJPH.2014.302111","article-title":"Wounds on wheels: implementing a specialized wound clinic within an established syringe exchange program in Baltimore, Maryland","volume":"104","author":"Robinowitz","year":"2014","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.josat.2024.209586_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108553","article-title":"Mobile low-threshold buprenorphine integrated with infectious disease services","volume":"133","author":"Rosecrans","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"Suppl 2","key":"10.1016\/j.josat.2024.209586_bb4000","article-title":"Collocated buprenorphine is associated with improved HCV visit adherence in people who inject drugs (PWID): Data from the anchor study","volume":"6","author":"Rosenthal","year":"2019","journal-title":"Open Forum Infectious Diseases"},{"issue":"7","key":"10.1016\/j.josat.2024.209586_bb5000","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/cid\/ciaa105","article-title":"Concurrent initiation of hepatitis c and opioid use disorder treatment in people who inject drugs","volume":"71","author":"Rosenthal","year":"2020","journal-title":"Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America"},{"issue":"5","key":"10.1016\/j.josat.2024.209586_bb0150","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/10826084.2023.2177972","article-title":"Scope of, motivations for, and outcomes associated with buprenorphine diversion in the United States: A scoping review","volume":"58","author":"Rubel","year":"2023","journal-title":"Substance Use & Misuse"},{"issue":"10","key":"10.1016\/j.josat.2024.209586_bb6000","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1089\/wound.2020.1243","article-title":"Wounds and Skin and Soft Tissue Infections in People Who Inject Drugs and the Utility of Syringe Service Programs in Their Management","volume":"10","author":"Sanchez","year":"2021","journal-title":"Advances in Wound Care"},{"issue":"3","key":"10.1016\/j.josat.2024.209586_bb0155","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/08897077231179576","article-title":"National trends in buprenorphine treatment for opioid use disorder from 2007 to 2018","volume":"44","author":"Schuler","year":"2023","journal-title":"Substance Abuse"},{"key":"10.1016\/j.josat.2024.209586_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2023.208981","article-title":"Higher buprenorphine dose associated with increased treatment retention at low threshold buprenorphine clinic: A retrospective cohort study","volume":"147","author":"Selitsky","year":"2023","journal-title":"Journal of Substance use and Addiction Treatment"},{"key":"10.1016\/j.josat.2024.209586_bb7000","article-title":"Integrated models of care for people who inject drugs and live with hepatitis C virus: A systematic review","volume":"10","author":"Soc\u00edas","year":"2019","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2024.209586_bb0165","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"1","key":"10.1016\/j.josat.2024.209586_bb0170","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13722-023-00427-5","article-title":"Mobile service delivery in response to the opioid epidemic in Philadelphia","volume":"18","author":"Stewart","year":"2023","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.josat.2024.209586_bb0175","author":"The American Society of Addiction Medicine"},{"issue":"2","key":"10.1016\/j.josat.2024.209586_bb0180","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2024.209586_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108848","article-title":"Predictors of engagement and retention in care at a low-threshold substance use disorder bridge clinic","volume":"141","author":"Wakeman","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"7","key":"10.1016\/j.josat.2024.209586_bb0190","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"American Journal of Epidemiology"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875924002984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875924002984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T17:26:38Z","timestamp":1739208398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875924002984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":45,"alternative-id":["S2949875924002984"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2024.209586","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redefining low-threshold buprenorphine access in an integrated mobile clinic program: Factors associated with treatment retention","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2024.209586","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"209586"}}